Workflow
McKesson Corporation
icon
Search documents
Landstar Appoints Chief Human Resources Officer
Globenewswire· 2026-02-02 21:05
Core Insights - Landstar System, Inc. has appointed Ms. Terri Lewis as Chief Human Resources Officer (CHRO), effective February 23, 2026, to enhance its human resources strategy and support long-term growth [1][3] Company Overview - Landstar System, Inc. is a technology-enabled, asset-light provider of integrated transportation management solutions, delivering specialized transportation services to a diverse customer base [5] - The company operates through a network of agents, third-party capacity providers, and employees, and is headquartered in Jacksonville, Florida [5] Leadership Appointment - Ms. Terri Lewis brings over 25 years of human resources leadership experience from both public and private sectors, previously serving as Chief People Officer at One Call [2] - Lewis has held senior roles in various organizations, including Pontoon Solutions and General Electric, and holds a master's degree in human resources management [2] Responsibilities of CHRO - As CHRO, Lewis will oversee talent acquisition, retention, leadership effectiveness, learning and development, succession planning, and employee relations [3] - She will collaborate with executive leadership and the Board of Directors to foster a high-performance culture and strengthen Landstar's employer brand [3] Executive Statements - Frank Lonegro, President and CEO of Landstar, expressed confidence in Lewis's capabilities to support the company's network and enhance its people strategies [4] - Lewis emphasized her commitment to supporting the team and driving collective success within the organization [4]
McKesson (NYSE:MCK) FY Earnings Call Presentation
2026-01-13 17:45
McKesson Corporation J.P. Morgan Healthcare Conference January 13, 2026 Brian Tyler Chief Executive Officer 1 © 2026 McKesson Corporation. All rights reserved. Cautionary Statements Cautionary Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward- looking statements may be identified by their use of terminology such as "believes," "expects," "anticipates," "may," "will," ...
Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings?
ZACKS· 2025-08-05 16:46
Core Insights - Solventum (SOLV) is set to release its second-quarter 2025 results on August 7, with previous earnings surpassing estimates by 12.61% and a trailing four-quarter average surprise of 11.48% [1][2] Financial Estimates - The Zacks Consensus Estimate for Solventum's revenues is $2.12 billion, while the earnings estimate is $1.45 per share [2] Segment Performance - The MedSurg segment achieved 6% organic growth in the last quarter, driven by strong contributions from Infection Prevention and Surgical Solutions, which rose 8.2%. Continued product adoption and improved execution are expected to support this segment, despite some anticipated moderation in growth due to earlier order timing [3] - The Dental Solutions segment experienced a modest 0.4% organic growth, reflecting a softer market. However, steady demand for core products and new launches are expected to stabilize performance in the upcoming quarter [4] - The Health Information Systems (HIS) segment posted nearly 4% organic growth, supported by strong customer retention in revenue cycle management software. Continued interest in AI-powered tools is expected to maintain steady growth [5] - The Purification and Filtration segment grew 2.2% organically, with solid demand in bioprocessing. This segment is anticipated to remain stable despite preparations for divestiture later this year [6] Strategic Developments - Investors are keen on updates regarding Solventum's three-phase transformation plan, which includes exiting over 30% of transition service agreements and executing a significant ERP deployment [7] - The company raised its full-year organic revenue growth guidance to 1.5% to 2.5%, reflecting stronger volume trends. Adjusted earnings per share are expected to remain between $5.45 and $5.65, despite anticipated tariff headwinds [10] Tariff Impact - Solventum expects an $80 to $100 million impact from tariffs in the second half of the year, which will pressure margins but not revenue. An update on the planned divestiture of the Purification and Filtration business is also anticipated [9]